At the height of the pandemic, routine cancer screenings declined by 90 percent. Screenings are resuming and doctors are diagnosing later-stage cancers — cancers that might have been caught earlier. NPR science correspondent Yuki Noguchi talks about whom this affects most, and about the ripple effects that missing cancer screening may have for years to come.
